Mills Biopharmaceuticals Overview
- Founded
-
1992
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Financing Rounds
-
4
Mills Biopharmaceuticals General Information
Description
Provider of brachytherapy treatment services. The company is engaged in supplying of Iodine 125 and Palladium Pd-103 seeds for low dose prostate brachytherapy treatment.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Drug Delivery
Acquirer
Primary Office
- 120 NorthEast 26th Street
- Oklahoma City, OK 73105
- United States
Mills Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Mills Biopharmaceuticals Patents
Mills Biopharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20090057580-A1 | Radiation shielding device | Active | 13-Aug-2004 | 0000000000 | |
| US-7425195-B2 | Radiation shielding device | Inactive | 13-Aug-2004 | 0000000000 | |
| US-8360952-B2 | Radiation shielding device | Inactive | 13-Aug-2004 | 0000000000 | |
| US-20060063960-A1 | Radiation shielding device | Active | 13-Aug-2004 | 0000000000 | |
| AU-2005333220-A1 | Radiation shielding device | Inactive | 13-Aug-2004 | A61N5/1027 |
Mills Biopharmaceuticals Executive Team (1)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Stanley Mills | Founder & President |
Mills Biopharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|